MVMatti K Viljanen

Matti K Viljanen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Matti K Viljanen has a total of 4 co-authors. Here are the top co-authors by number of shared publications:

  • Arja H Viinanen

    Turku University Central Hospital, Department of Pulmonary Diseases, Preitilä, Finland

    1 shared publication
  • Hanna Soini

    National Public Health Institute, Department in Turku, Turku, Finland

    1 shared publication
  • Kari Liippo

    Turku University Central Hospital, Department of Pulmonary Diseases, Preitilä, Finland

    1 shared publication
  • Merja Marjamäki

    National Public Health Institute, Department in Turku, Turku, Finland

    1 shared publication

Latest Publications

  • Ligase chain reaction assay is clinically useful in the discrimination of smear-positive pulmonary tuberculosis from atypical mycobacterioses

    by Arja H Viinanen, Kari Liippo, Hanna Soini, Merja Marjamäki, Matti K Viljanen

    We evaluated the usefulness of the ligase chain reaction (LCR) (Abbott LCx Mycobacterium tuberculosis assay) during the initial diagnosis of tuberculosis. LCx was carried out in parallel with conventional methods for the analysis of clinical samples. Out of 86 patients who were examined clinically, 53 were suspected of having pulmonary tuberculosis, eight had residual X-ray scars from previous tuberculosis and 25 served as asymptomatic controls. Ten bronchoscopy samples and 237 sputum samples were analysed by direct microscopy, culture and LCx. All 11 smear-positive and two of three smear-negative tuberculosis patients had at least one LCx-positive specimen. All samples that were both LCx and smear-positive were culture-positive for M. tuberculosis. The smear-positive samples from the five patients with atypical mycobacteriosis were LCx-negative. There were three false-positive results: one in a smear-negative sample from a patient with M. malmoense infection and two from two pneumonia patients. All samples from controls and patients with previous tuberculosis were LCx-negative. The sensitivity, specificity and the positive and negative predictive values of LCx in patient analysis were 92.9%, 95.8%, 81.3% and 98.6%, respectively. LCx assay of M. tuberculosis is useful in rapid confirmation of tuberculosis or atypical mycobacteriosis from a smear-positive sample and may aid in diagnosing smear-negative tuberculosis.